F-1/A 1 formf-1a.htm

 

As filed with the Securities and Exchange Commission on June 21, 2023

 

Registration Statement No. 333-267778

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Amendment No. 5 to

FORM F-1

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

 

FITELL CORPORATION

(Exact name of registrant as specified in its charter)

 

Cayman Islands   3949   Not Applicable

(State or other jurisdiction of

incorporation or organization)

 

(Primary Standard Industrial

Classification Code Number)

 

(I.R.S. Employer

Identification Number)

 

23-25 Mangrove Lane

Taren Point, NSW 2229

Australia

+612 95245266

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Cogency Global Inc.

122 East 42nd Street, 18th Floor

New York, NY 10168

(800) 221-0102

(Name, address, including zip code, and telephone number, including area code, of agent for service)

 

With a Copy to:

 

Mark E. Crone, Esq.

Liang Shih, Esq.

The Crone Law Group P.C.

420 Lexington Avenue, Suite 2446

New York, NY 10170

Tel: 646.861.7891

 

Michael J. Blankenship, Esq.

Winston & Strawn LLP

800 Capitol Street, Suite 2400

Houston, TX 77002-2925

Tel: 713.651.2678

 

Approximate date of commencement of proposed sale to the public: Promptly after the effective date of this registration statement.

 

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following box: ☐

 

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

 

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

 

If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933.

 

Emerging growth company ☒

 

If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

 

The Registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until the registration statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to such Section 8(a), may determine.

 

 

 

 
 

 

EXPLANATORY NOTE

 

Fitell Corporation is filing this Amendment No. 5 (“Amendment No. 5”) to the Registration Statement on Form F-1 (Registration No. 333-267778), originally filed on October 7, 2022 (the “Registration Statement”), as an exhibit-only filing solely to update and file Exhibit 23.1. Accordingly, this Amendment No. 5 consists only of the facing page, this explanatory note, Item 8 of Part II of the Registration Statement, the signature pages to the Registration Statement, and the exhibit being filed with this Amendment No. 5. The prospectus and the balance of Part II of the Registration Statement are unchanged and have been omitted.

 

 

 

 

PART II

 

INFORMATION NOT REQUIRED IN PROSPECTUS

 

Item 8. Exhibits and Financial Statement Schedules

 

Exhibits and Financial Statement Schedules

 

(a) Exhibits

 

See Exhibit Index beginning on page II-2 of this registration statement.

 

(b) Financial Statement Schedules

 

Schedules have been omitted because the information required to be set forth therein is not applicable or is shown in the Financial Statements or the Notes thereto.

 

II-1

 

 

EXHIBIT INDEX

 

Exhibit No.   Description
1.1   Form of Underwriting Agreement*
2.1   Share Exchange Agreement, dated as of May 5, 2022, by and among Fitell Corporation, KMAS Capital and Investment Pty Ltd, and SKMA Capital and Investment Ltd.*
3.1   Memorandum and Articles of Association*
3.2   Certificate of Registration of See Trading Co. Pty Ltd*
3.3   Certificate of Registration of See Trading Co. Pty Ltd (name change to GD Wellness Pty Ltd)*
3.4   Certificate of Registration of KMAS Capital and Investment Pty Ltd*
4.1   Specimen Certificate for Ordinary Shares*
4.2   Representatives’ Warrants (included in Exhibit 1.1)*
5.1   Opinion of Ogier regarding the validity of the Ordinary Shares being registered*
5.2   Opinion of The Crone Law Group P.C. regarding the enforceability of the Representatives’ Warrants*
10.1   Unsecured Loan Agreement, dated as of March 10, 2020, by and between GD Wellness Pty Ltd and Ansa Group Limited*
10.2   Form of Indemnification Agreement between the registrant and its officers and directors*
10.3   Form of Director Agreement between the registrant and its directors*
10.4   Form of Independent Director Agreement between the registrant and its independent directors*
10.5   Form of Employment Agreement between the registrant and its officers*
10.6  

Lease Agreement*

10.7

 

Form of Lock-Up Agreement*

10.8   License Agreement, dated as of November 9, 2021, by and between GD Wellness Pty Ltd and Js & Je Company Limited*
21.1   Subsidiaries*
23.1   Consent of Accell Audit and Compliance, P.A.**
23.2   Consent of Ogier (included in Exhibit 5.1)*
23.3   Consent of The Crone Law Group P.C. (included in Exhibit 5.2)*
24.1   Power of Attorney*
99.1   Code of Business Conduct and Ethics of the registrant*
99.2   Audit Committee Charter*
99.3   Nominating Committee Charter*
99.4   Compensation Committee Charter*
99.5   Consent of Mr. Leighton*
99.6   Consent of Mr. Wu*
99.7   Consent of Mr. Ross*
107   Filing Fee Table*

 

* Previously filed.

** Filed herewith.

 

II-2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form F-1 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Taren Point, New South Wales, Australia, June 21, 2023.

 

  Fitell Corporation
     
  By: /s/ Guy Adrian Robertson
  Name: Guy Adrian Robertson
  Title: Chief Executive Officer and Director
     
  By: /s/ Jamarson Kong
  Name: Jamarson Kong
  Title:

Chief Financial Officer

 

Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature   Capacity   Date
         
/s/ Guy Adrian Robertson   Chief Executive Officer and Director   June 21, 2023
Guy Adrian Robertson   (principal executive officer)    
         
/s/ Jamarson Kong  

Chief Financial Officer

(principal financial and accounting officer)

  June 21, 2023
Jamarson Kong        
         
/s/ *   Director   June 21, 2023
Jieting Zhao        
         
/s/ *   Director   June 21, 2023
Yinying Lu        

 

*By: /s/ Guy Adrian Robertson  
  Guy Adrian Robertson  
  Attorney-in-Fact  

 

SIGNATURE OF AUTHORIZED REPRESENTATIVE IN THE UNITED STATES

 

Pursuant to the Securities Act of 1933 as amended, the undersigned, the duly authorized representative in the United States of America, has signed this registration statement thereto in New York, New York on June 21, 2023.

 

  Authorized U.S. Representative
                  
  By:  /s/ Maggie Zhang
  Name: Maggie Zhang

 

II-3